| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 24.32 | -11.41 | -25.61 | -14.25 |
Op profit growth | 6.71 | -295.42 | -262.34 | -308.68 |
EBIT growth | -43.32 | -65.39 | 30.41 | -19.74 |
Net profit growth | -98.32 | -11.09 | -62.84 | -28.79 |
Profitability ratios (%) | ||||
OPM | 9.49 | 11.06 | -5.01 | 2.29 |
EBIT margin | -4.44 | -9.75 | -24.98 | -14.24 |
Net profit margin | -0.34 | -25.89 | -25.79 | -51.65 |
RoCE | -2.2 | -3.14 | -6.28 | -3.74 |
RoNW | -0.07 | -4.1 | 254.3 | 14.01 |
RoA | -0.04 | -2.08 | -1.62 | -3.39 |
Per share ratios (₹) | ||||
EPS | 0.39 | -28.55 | -32.11 | 0 |
Dividend per share | 0 | 0 | 0 | 0 |
Cash EPS | -21.79 | -55.23 | -62.96 | -54.63 |
Book value per share | 158.6 | 159.96 | 187.66 | -88.99 |
Valuation ratios | ||||
P/E | 728.97 | -86.34 | 0 | |
P/CEPS | -13.04 | -44.63 | -0.2 | |
P/B | 1.79 | 15.41 | -0.12 | |
EV/EBIDTA | 22.85 | 161.44 | 83.19 | |
Payout (%) | ||||
Dividend payout | 0 | 0 | 0 | 0 |
Tax payout | 0 | 0 | 0 | -11.57 |
Liquidity ratios | ||||
Debtor days | 99.89 | 82.58 | 67.34 | 75.93 |
Inventory days | 106.17 | 119.45 | 120.49 | 108.21 |
Creditor days | -100.04 | -96.45 | -157.48 | -216.58 |
Leverage ratios | ||||
Interest coverage | 0.77 | 0.85 | 30.51 | 0.32 |
Net debt / equity | 0.4 | 0.66 | 0.51 | -3.65 |
Net debt / op. profit | 4.89 | 8.69 | -15.39 | 184.54 |
Cost breakup (₹) | ||||
Material costs | -56.03 | -50.77 | -47.88 | -51.27 |
Employee costs | -11.3 | -14.91 | -16.68 | -12.62 |
Other costs | -23.15 | -23.25 | -40.44 | -33.8 |
At around 12.53 PM, Orchid Pharma was trading 5% higher at ₹740.40, against the previous close of ₹705.15 on NSE.
The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
